Versatile types of inorganic/organic NIR-IIa/IIb fluorophores: from strategic design toward molecular imaging and theranostics

Y Liu, Y Li, S Koo, Y Sun, Y Liu, X Liu, Y Pan… - Chemical …, 2021 - ACS Publications
In vivo imaging in the second near-infrared window (NIR-II, 1000–1700 nm), which enables
us to look deeply into living subjects, is producing marvelous opportunities for biomedical …

Nanomaterials for cancer therapy: current progress and perspectives

Z Cheng, M Li, R Dey, Y Chen - Journal of hematology & oncology, 2021 - Springer
Cancer is a disease with complex pathological process. Current chemotherapy faces
problems such as lack of specificity, cytotoxicity, induction of multi-drug resistance and stem …

Nanocrystal quantum dots: from discovery to modern development

AL Efros, LE Brus - ACS nano, 2021 - ACS Publications
This review traces nanocrystal quantum dot (QD) research from the early discoveries to the
present day and into the future. We describe the extensive body of theoretical and …

Recent progress of fluorescent materials for fingermarks detection in forensic science and anti-counterfeiting

AA Ansari, KM Aldajani, AN AlHazaa… - Coordination Chemistry …, 2022 - Elsevier
This review summarized the applied techniques and applied nanomaterials (NMs) for the
progress of latent fingerprints (LFPs) images on several surfaces. Used numerous types of …

Alzheimer's disease: pathogenesis, diagnostics, and therapeutics

S Tiwari, V Atluri, A Kaushik, A Yndart… - International journal of …, 2019 - Taylor & Francis
Currently, 47 million people live with dementia globally, and it is estimated to increase more
than threefold (~ 131 million) by 2050. Alzheimer's disease (AD) is one of the major …

Nanocarriers-mediated drug delivery systems for anticancer agents: an overview and perspectives

Z Edis, J Wang, MK Waqas, M Ijaz… - International journal of …, 2021 - Taylor & Francis
Nanotechnology has been actively integrated as drug carriers over the last few years to treat
various cancers. The main hurdle in the clinical management of cancer is the development …

[HTML][HTML] Application of nanotechnology in cancer diagnosis and therapy-a mini-review

C Jin, K Wang, A Oppong-Gyebi… - International Journal of …, 2020 - ncbi.nlm.nih.gov
Cancer is a leading cause of death and poor quality of life globally. Even though several
strategies are devised to reduce deaths, reduce chronic pain and improve the quality of life …

Controlled drug delivery vehicles for cancer treatment and their performance

S Senapati, AK Mahanta, S Kumar… - Signal transduction and …, 2018 - nature.com
Although conventional chemotherapy has been successful to some extent, the main
drawbacks of chemotherapy are its poor bioavailability, high-dose requirements, adverse …

Intracellular delivery by membrane disruption: mechanisms, strategies, and concepts

MP Stewart, R Langer, KF Jensen - Chemical reviews, 2018 - ACS Publications
Intracellular delivery is a key step in biological research and has enabled decades of
biomedical discoveries. It is also becoming increasingly important in industrial and medical …

Advances in lung cancer treatment using nanomedicines

A Sharma, D Shambhwani, S Pandey, J Singh… - ACS …, 2022 - ACS Publications
Carcinoma of the lungs is among the most menacing forms of malignancy and has a poor
prognosis, with a low overall survival rate due to delayed detection and ineffectiveness of …